Financial Tearsheet






Financial Tearsheet

Cronos Group is an innovative global cannabinoid company with international production and distribution networks across five continents. The Company is committed to building disruptive intellectual property and establishing an iconic brand portfolio.

Stock Chart

Stock Quote

Data Provided by Refinitiv. Minimum 15 minutes delayed.

News Releases

26 Feb 21
Cronos Group Reports 2020 Fourth Quarter and Full-Year Results
Announces plans to launch Happy Dance™ in ULTA Beauty™ Cronos Israel continues to grow the PEACE NATURALS™ brand in the Israeli medical cannabis market Preserves robust balance sheet with approximately USD$1.3 billion in cash and short-term investments TORONTO , Feb.
12 Feb 21
Cronos Group Inc. to Hold 2020 Fourth Quarter and Full-Year Earnings Conference Call on February 26, 2021
TORONTO , Feb. 12, 2021 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos Group” or the “Company”) will hold its 2020 Fourth Quarter and Full-year Earnings Conference Call on Friday, February 26, 2021 at 8:30 a.m. EST . Cronos Group’s senior management team will discuss the
20 Jan 21
Cronos Group Inc. to Speak at the 24th Annual CIBC Western Institutional Investor Conference
TORONTO , Jan. 20, 2021 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos Group” or the “Company”), an innovative global cannabinoid company, today announced that Kurt Schmidt, President and Chief Executive Officer, will speak at the 24th Annual CIBC Western Institutional

SEC Filings

Filing date Description

40FR12B

F-X

Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act

Events

26 February 2021 at 8:30 AM EST
Cronos Group Full Year and Fourth Quarter 2020 Earnings Conference Call
22 January 2021 at 4:10 PM EST
Cronos Group at the 24th Annual CIBC Western Institutional Investor Conference
16 December 2020 at 12:30 PM EST
The Road Ahead, Preparation for 2021: MKM Partners Virtual Conference